Nov. 14, 2014 – Prestige Medical Imaging (PMI) will partner with VuCOMP Inc., a developer of advanced computer vision systems for the detection of breast cancer. VuCOMP has developed and commercialized two breast-imaging products, M-Vu CAD and M-Vu Breast Density. M-Vu CAD analyzes mammograms to mark areas consistent with breast cancer using sophisticated mathematical algorithms.
M-Vu Breast Density is designed to advance the science of breast density measurement by identifying dense tissue in the breast that could be masking cancer. In addition, VuCOMP has a works-in-progress CAD solution for 3-D breast tomosynthesis in development.
CEO of Prestige Medical Imaging Bill Haussmann, Chief Executive Officer commented, “Our customers are requiring more advanced technology in performing diagnostic exams particularly with reading dense breast tissue mammography exams. The addition of VuCOMP’s innovative technology to Prestige Medical Imaging’s portfolio addresses these needs by offering an automated, consistent and efficient assessment tool. This offering expands our portfolio and extends our market reach into Women’s Healthcare.”
For more information: www.prestigemedicalimaging.com, www.vucomp.com
February 18, 2026 
